Home › Funds › Boussard & Gavaudan Investment Management LLP › ANIP

Boussard & Gavaudan Investment Management LLP position in ANIP

ANI PHARMACEUTICALS INC COM · Health Care

Boussard & Gavaudan Investment Management LLP reported holding 13,350 shares of ANIP (ANI PHARMACEUTICALS INC COM) in its Q1 2026 13F filing — a position valued at US$16.5M, representing 1.80% of its reported portfolio and ranking #16 among its reported holdings. Boussard & Gavaudan Investment Management LLP has disclosed ANIP holdings in 3 of the last 3 reported quarters, going back to Q3 2025.

Latest position (Q1 2026)13.35K sh
Reported value held$16.46M
Portfolio Weight1.80%
First reportedQ3 2025
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Boussard & Gavaudan Investment Management LLP's ANIP position evolved

Boussard & Gavaudan Investment Management LLP first disclosed a stake in ANIP in Q3 2025 at 10,000 shares (US$14.1M). The position peaked in Q4 2025 at 18,500 shares, worth US$23.6M. Across 3 filings, Boussard & Gavaudan Investment Management LLP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 13,350 shares valued at US$16.5M — a reduction of -5,150 shares quarter over quarter.. Notable position changes include a 85% increase in Q4 2025 (shares fell 3% over the following quarter), a 28% trim in Q1 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 10.00K $14.11M New
Q4 2025 18.50K $23.58M Add
Q1 2026 13.35K $16.46M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANIP and 13F data

ANIP (ANI PHARMACEUTICALS INC COM) is a Health Care company. 48 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIP

All ANIP fund holders →

FAQ

How long has Boussard & Gavaudan Investment Management LLP held ANIP?

Boussard & Gavaudan Investment Management LLP has disclosed ANIP holdings in 3 of the last 3 reported quarters, going back to Q3 2025.

What is Boussard & Gavaudan Investment Management LLP's current position in ANIP?

As of Q1 2026, Boussard & Gavaudan Investment Management LLP holds 13.35K shares of ANIP (ANI PHARMACEUTICALS INC COM), valued at $16.46M, representing 1.80% of its reported portfolio and ranking #16.

Has Boussard & Gavaudan Investment Management LLP been buying or selling ANIP?

In the latest 13F filing (Q1 2026), Boussard & Gavaudan Investment Management LLP reduced its position in ANIP. The position peaked in Q4 2025 at 18.50K shares.

Which other funds hold ANIP?

Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.